Aehr Test Systems

Aehr Test Systems (AEHR) Market Cap

Aehr Test Systems has a market capitalization of $2.61B.

Price: $79.98

3.11 (4.05%)

Market Cap: 2.61B

NASDAQ · time unavailable

CEO: Gayn Erickson

Sector: Technology

Industry: Semiconductors

IPO Date: 1997-08-15

Website: https://www.aehr.com

Aehr Test Systems (AEHR) - Company Information

Market Cap: 2.61B|Sector: Technology

Company Profile

Aehr Test Systems, founded in 1977 and based in Fremont, California, specializes in the global provision of advanced burn-in and test systems for integrated circuits, encompassing logic, optical, and memory devices. Its extensive product lineup includes the ABTS and FOX-P families of test and burn-in solutions, complemented by specialized components such as the FOX WaferPak Aligner, FOX-XP WaferPak Contactor, FOX DiePak Carrier, and FOX DiePak Loader. The ABTS system is specifically designed for both production and qualification assessments of packaged parts, covering a range of lower and higher power logic devices, as well as various memory types. For more complex integrated circuits like memories, digital signal processors, microprocessors, microcontrollers, systems-on-a-chip, and integrated optical devices, the FOX-XP and FOX-NP systems facilitate burn-in and functional testing at both the wafer and individual die/module levels. Aehr's FOX-CP system offers a compact, single-wafer solution for verifying the reliability of logic, memory, and photonic devices. A distinguishing offering, the WaferPak Contactor, features an exclusive full-wafer probe card, accommodating wafers up to 300mm, which enables semiconductor manufacturers to conduct comprehensive wafer-level testing and burn-in on Aehr's FOX platforms. Furthermore, the DiePak Carrier provides a reusable, temporary packaging medium, empowering IC manufacturers to complete final testing and burn-in processes for bare die and modules.

Analyst Sentiment

87%
Strong Buy

From 5 Active Polls

1Y Forecast: $117.50

▲ +46.9% Potential Upside

Consensus Target Metrics

Low Bound

$110

Median

$118

High Bound

$125

Average

$118

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$117.50
▲ +46.91% Upside
Low Target
$110.00
38% Risk
Median Target
$117.50
47% Mid
High Target
$125.00
56% Max
Consensus
Hold
1 / 3 Buys

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

📊 Historical Valuation Multiples

Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.

Fiscal QuarterTTMQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Period EndingTrailing 12MMay 29, 2026Feb 27, 2026Nov 28, 2025Aug 29, 2025May 30, 2025Feb 28, 2025Nov 29, 2024Aug 30, 2024
Market Cap ($M)2,6092,8321,149690747285287353443
Enterprise Value ($M)2,5032,7251,122670734270263326412
Price to Earnings Ratio (P/E)-347.74465.37-93.57-52.20-89.62-24.54-111.57-85.66167.51
Price/Earnings-to-Growth Ratio (PEG)5.09-21.56-3.09-33.65
Price to Sales Ratio (P/S)51.24143.37111.4069.8368.0620.1915.6626.2133.75
Price to Book Ratio (P/B)11.1712.908.285.286.102.322.312.863.61
Price to Free Cash Flow Ratio (P/FCF)-485.302629.22-392.52-372.50-446.25-55.57-87.90-56.93202.80
Enterprise Value to Sales (EV/Sales)137.98108.8067.7466.9619.1714.3624.2331.37
Enterprise Value to EBITDA (EV/EBITDA)-213.23-1299.57-357.22-187.40-251.11-137.397513.00-926.16298.26
Debt to Equity Ratio9.070.050.070.080.090.090.050.050.05

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 AEHR TEST SYSTEMS (AEHR) — Investment Overview

🧩 Business Model Overview

AEHR Test Systems designs and manufactures automated test systems used in semiconductor device verification, including reliability-focused workflows such as burn-in and high-speed production testing. The company sells complex, application-specific platforms to semiconductor manufacturers and outsourced semiconductor assembly & test (OSAT) providers. In practice, AEHR’s value chain spans (1) engineering-led system design aligned to device characteristics and test requirements, (2) hardware and control-system integration, (3) installation and qualification with customer processes, and (4) ongoing service/support and system upgrades. Customer adoption tends to be “stickier” than typical standalone industrial equipment because test systems must be integrated into a customer’s characterization flow, software environment, and manufacturing controls.

💰 Revenue Streams & Monetisation Model

AEHR’s monetisation primarily comes from:
  • System sales (transactional): One-time revenue tied to new test capacity, technology transitions, and qualification cycles.
  • Service and maintenance (more recurring): Support, preventive maintenance, spares, and maintenance programs that sustain uptime and protect test performance.
  • Upgrades / engineering add-ons (opportunistic recurring component): Enhancements to match evolving device requirements, higher throughput needs, or reliability/test coverage improvements.
Margin drivers: System gross margins are influenced by product mix, complexity of the application engineering, and manufacturing leverage. Service and maintenance typically carry comparatively steadier contribution margins due to installed-base coverage, making the installed base an important driver of earnings quality over time.

🧠 Competitive Advantages & Market Positioning

AEHR’s most tangible moat is high switching costs driven by integration and qualification requirements, combined with technical know-how embedded in custom test system configurations.
  • High switching costs (test program + process integration): Once a platform is qualified for a specific device family and production flow, customers incur meaningful costs to validate new systems—both in engineering time and in manufacturing disruption risk.
  • Installed-base learning and know-how: AEHR’s repeated deployment across device/test types supports iterative improvements in throughput, reliability workflows, and system configuration efficiency.
  • IP and engineering barriers: Test systems rely on specialized architecture and control/measurement methods; these create friction for entrants attempting to match performance across multiple device generations.
Competitive benchmarking:
  • Teradyne: Broad ATE portfolio across multiple semiconductor end markets, often competing on scale and platform breadth.
  • Advantest: Large-scale tester platforms with extensive coverage across wafer sort and production test use cases.
  • FormFactor: While not a direct “system” peer for AEHR’s specific reliability/test platform niche, it competes for critical test-adjacent subsystems (notably probe-related technologies), reflecting how competitors can influence the testing stack.
Positioning contrast: AEHR generally emphasizes tailored test systems for demanding reliability/production needs where integration, speed-to-qualification, and application-specific performance matter. Larger ATE players often compete more aggressively where customers want broad platform consolidation; AEHR’s differentiation tends to be most visible when device characteristics and test throughput/reliability requirements favor a specialized solution with faster engineering iteration and lower integration risk.

🚀 Multi-Year Growth Drivers

Key secular drivers that can expand AEHR’s addressable market over a 5–10 year horizon include:
  • Semiconductor content growth and device complexity: More sophisticated memory and logic designs increase the amount and complexity of test and reliability validation per unit.
  • Reliability and burn-in intensity: As feature sizes and operating conditions become more demanding, ensuring stable performance increases the importance of structured reliability workflows.
  • Outsourcing and capacity dispersion: OSAT participation and regional manufacturing strategies can require incremental test capacity, new system qualifications, and upgrades.
  • Technology transitions and throughput upgrades: Device generation changes and process shrinks typically trigger test-system requalification and performance upgrades, supporting the services and upgrade revenue stream.
The practical implication: AEHR’s TAM expands not only with semiconductor volume, but also with the frequency of device transitions that require new or upgraded test capability.

⚠ Risk Factors to Monitor

  • Semiconductor equipment cyclicality: Test system purchases are tied to customer capex cycles; demand can weaken when memory/logic investment budgets compress.
  • Qualification timelines and backlog quality: System revenue depends on customer engineering acceptance and factory readiness; delays can shift revenue recognition even when demand exists.
  • Technological evolution in test requirements: Changes in device physics, test coverage expectations, or measurement approaches may require continuous engineering investment and platform updates.
  • Competitive pressure from larger ATE providers: Competitors with broader installed bases may offer bundled solutions or aggressive pricing when customers pursue platform consolidation.
  • Concentration risk: Exposure to a limited set of major customer programs can increase volatility in system demand and service utilization.

📊 Valuation & Market View

AEHR is typically valued by equity markets as a semiconductor capital equipment and service-enabled industrial technology company. Common approaches include:
  • EV/EBITDA for assessing operating leverage once utilization improves, driven by gross margin stability and operating expense discipline.
  • P/S for capturing platform growth expectations where profitability is impacted by cycle-related volume swings.
Drivers that move the needle: investor focus generally centers on backlog visibility, conversion of backlog to recognized revenue, gross margin durability across system mix, and the resilience/expansion of service-related revenue linked to the installed base.

🔍 Investment Takeaway

AEHR’s long-term investment appeal rests on integration-driven switching costs and engineering-led specialization in high-demand reliability/production test workflows. While end-market cyclicality is a structural feature of semiconductor equipment, the installed base supports a pathway for steadier service and upgrade contribution, and qualification-driven adoption can provide durability versus competitors offering more generalized platforms.

⚠ AI-generated — informational only. Validate using filings before investing.

📰 Market News & Coverage

15 Stories Available

Real-time institutional reporting and market updates for AEHR.

zacks.com2026-07-31

Why Aehr Test Systems (AEHR) Might be Well Poised for a Surge

Aehr Test Systems (AEHR) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

zacks.com2026-07-31

Can Aehr Test Systems (AEHR) Climb 49.6% to Reach the Level Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 49.6% in Aehr Test Systems (AEHR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

zacks.com2026-07-30

FORM vs. AEHR: Which Semi Test Equipment Stock is a Better Buy?

Aehr's record bookings, AI-driven backlog and expanding burn-in portfolio give it the edge over FormFactor for long-term growth.

zacks.com2026-07-28

Here's Why Aehr Test Systems (AEHR) Could be Great Choice for a Bottom Fisher

After losing some value lately, a hammer chart pattern has been formed for Aehr Test Systems (AEHR), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.

fool.com2026-07-24

Here's Why Aehr Test Systems Stock Surged Higher This Week

Investors bought the stock ahead of some of its potential customers reporting this week. Aehr is a small company, and even a few large orders are potential game changers for it.

seekingalpha.com2026-07-22

Aehr Test Systems: The AI Bottleneck Play

Aehr Test Systems transformed from an EV silicon carbide supplier into an AI infrastructure company, with AI processors and silicon photonics generating 91% of revenue. Fourth-quarter bookings surged to a record $60.7 million, lifting effective backlog to approximately $100.6 million and supporting 160%-200% FY2027 revenue growth. Wafer-level burn-in is becoming increasingly critical as larger AI processors integrate HBM memory and chiplets, reducing costly packaging failures.

zacks.com2026-07-20

Best Momentum Stocks to Buy for July 20th

STT, AEHR and NBIS made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 20, 2026.

zacks.com2026-07-20

Is Aehr Test Systems (AEHR) Stock Outpacing Its Computer and Technology Peers This Year?

Here is how Aehr Test Systems (AEHR) and Cisco Systems (CSCO) have performed compared to their sector so far this year.

zacks.com2026-07-20

New Strong Buy Stocks for July 20th

KTTA, NTRS, YEXT, AEHR and STT have been added to the Zacks Rank #1 (Strong Buy) List on July 20, 2026.

seekingalpha.com2026-07-18

Aehr Test Systems: Still Some Worry About The Blue-Sky Bull Case

Aehr Test Systems, Inc. has shifted its narrative from an EV supplier to a diversified AI-driven growth story. FY27 guidance projects 160–200% revenue growth, driven by AI accelerators, CPUs, and network processors, but customer concentration remains a risk. AEHR stock's valuation is high at ~18x FY27 revenue and ~45x gross profit, yet comparable to other AI winners if growth persists.

marketbeat.com2026-07-17

Aehr Test Systems Stock Soars on Earnings, Eyes Over 150% Revenue Growth

As AI stocks swing up and down, one name that has felt those movements as much as any is Aehr Test Systems NASDAQ: AEHR. This small stock has risen about 320% in 2026, and sits at a market capitalization of $2.7 billion in mid-July.

fool.com2026-07-17

Here's Why Aehr Test Systems Surged Higher This Week

The company's end markets have evolved in recent years, shifting from EVs to AI processors. Management expects significant revenue growth in fiscal 2027, based on its orders and backlog.

fool.com2026-07-15

Why Aehr Test Systems Stock Surged Today

Aehr helps semiconductor companies test their products. Business is booming.

seekingalpha.com2026-07-15

Aehr Test Systems: The Earnings Reset Is Bigger Than The Rally

I am initiating Aehr Test Systems, Inc. with a Buy rating and a $144 price target, implying 50% upside from $96. The biggest driver is AI burn-in, where the $41 million hyperscale customer order supports my view that AEHR's Sonoma platform is moving from validation into real production demand. I have estimated about $1.0 in incremental EPS contribution, and using a 144x forward non-GAAP P/E multiple gives me a $144 price target, representing about 50% upside.

invezz.com2026-07-15

Why investors should consider selling AEHR stock on post-earnings rally

Aehr Test Systems (AEHR) is exploding higher on July 15 after posting blowout Q4 earnings and offering an absolute stunner of a forward guidance. In fiscal 2027, the company expects its revenue to come in at $140 million, nearly triple the topline figure last year and miles above the consensus set at $85 million only.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-05-29

"AEHR reported Q4’26 revenue of $18.8M, up sharply versus Q3’26 ($10.3M) and up modestly versus Q4’25 ($14.1M). Net income swung positive to +$1.39M (EPS $0.04), compared with a net loss in Q3’26 (-$3.20M) and Q4’25 (-$2.90M). Gross margin improved to 42.6% from 32.7% in Q3 and 30.3% in Q4’25, while operating margin moved from deeply negative to -5.2%—indicating profitability is improving, but still not fully absorbed at the operating level due to elevated operating expenses. Cash flow quality also strengthened: operating cash flow was +$1.83M and free cash flow was +$1.70M in Q4, versus materially negative operating cash flow in the prior two quarters. Balance sheet resilience is notable—cash and equivalents rose to $116.4M while total liabilities stayed low ($27.2M) and equity increased to $219.5M. For shareholder returns, the stock delivered extreme momentum (1y change +927.7%) with no dividend; buybacks were small ($1.11M) relative to the equity and cash base. Overall, Q4 shows clear operating and margin inflection, supported by a major cash balance and strongly positive price performance despite still-negative operating margin. Analyst targets imply upside versus the current price, though valuation looks stretched on many earnings-based metrics."

Revenue Growth

Good

Revenue rose QoQ from $10.31M (Q3’26) to $18.84M (Q4’26), a +82.6% QoQ jump, and improved YoY from $14.09M (Q4’25) to $18.84M (+33.7% YoY).

Profitability

Positive

Net income turned positive to +$1.39M from -$3.20M QoQ and -$2.90M YoY; gross margin expanded to 42.6% from 32.7% (QoQ) and 30.3% (YoY). Operating margin remains negative at -5.2%, so operating leverage is improving but not fully established.

Cash Flow Quality

Good

Q4 operating cash flow was +$1.83M and free cash flow +$1.70M, versus -$2.85M and -$1.39M in prior quarters. No dividends; buybacks were modest (-$1.11M), consistent with a growth/profitability inflection rather than cash-return focus.

Leverage & Balance Sheet

Strong

Strong liquidity with cash and equivalents at $116.4M. Net debt remains negative (-$106.5M), liabilities are low ($27.2M), and equity increased to $219.5M, supporting resilience through margin transition.

Shareholder Returns

Excellent

Total shareholder return is strongly supported by price momentum: 1y_change is +927.7%. There is no dividend; buybacks were small, so capital appreciation drives returns.

Analyst Sentiment & Valuation

Fair

Street target consensus is $62 (median $62) versus the current price context of $83.86, implying downside risk. Despite improving earnings, valuation remains demanding on earnings/cash-flow multiples.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

AEHR exited Q4 FY26 with a strong bookings/revenue inflection tied to AI and data-center burn-in demand, while restoring near-term profitability versus prior year. Q4 revenue rose 34% to $18.8M and non-GAAP gross margin expanded ~1,000 bps to 45%, supported by improved capacity utilization and product mix. Bookings surged to $60.7M (+500%+) and backlog hit a record $80.6M, later increased to ~$100.6M including the transition period. Management’s FY27 outlook is a major step-up: $130M-$150M revenue (+160% to +200% YoY) and 18%-22% non-GAAP pretax profitability. Catalysts are clearly wafer-level FOX (AI processors, silicon photonics) plus Sonoma package-level follow-on from a hyperscale customer, and expanding power semi coverage (GaN, silicon MOSFET, and silicon carbide recovery). Memory is deliberately excluded from FY27 assumptions, with execution and customer commitment still the gating risk. Capacity is addressed via contract manufacturing and a Taiwan expansion to support ramps.

AI IconGrowth Catalysts

  • AI processor wafer-level burn-in (FOX) ramp: lead AI processor customer doubling systems supplied and moving production screening to wafer-level on Aehr
  • Benchmark success for wafer-level burn-in on a major AI processor supplier, enabling pilot production test validation at their semiconductor contract manufacturer in Taiwan
  • Silicon photonics wafer-level burn-in momentum: lead customer ramping fully automated wafer-level systems with automated wafer handling (AGVs), plus follow-on orders for FOX cells and WaferPaks
  • Package-level burn-in momentum: record follow-on production orders from hyperscale customer for Sonoma systems (including next device forecast with ~2x power per package)
  • Power semiconductors expansion: GaN WaferPaks designs in sampling; first 300mm GaN wafer-level burn-in; first FOX system sold for silicon MOSFET wafer-level burn-in; silicon carbide recovery and additional $8M silicon carbide orders

Business Development

  • Lead AI processor customer: increased forecasted capacity needs for FOX systems and WaferPak full wafer contactors; requested pilot production validation for current high-volume device and a second device evaluation in parallel
  • Major silicon photonics customer (networking products leader): ordered 2 wafer FOX test cells and 2 FOX NPs after engaging in November; provided calendar-year forecast tied to next-gen hyperscale deployments
  • Lead hyperscale data center provider: record $41M purchase order (April) for Sonoma systems delivered to their OSAT in Taiwan; expanding Sonoma system purchases for a second, higher-power device
  • Silicon carbide win in Taiwan: selected Aehr over SemiNexus Test (Semi, reincorporated in Malaysia as Nexus Test) for silicon carbide wafer-level burn-in due to technical superiority/cost/IP and automotive production track record
  • Memory discussions: global leader in NAND flash benchmark completed; ongoing discussions with HBM DRAM and other DRAM/flash suppliers about testability changes and solution alignment

AI IconFinancial Highlights

  • Q4 revenue $18.8M, +34% YoY vs $14.1M; driven by FOX systems, WaferPak Aligners, and WaferPaks (AI/data center >80% of Q4 revenue vs 56% prior year)
  • Non-GAAP gross margin Q4 45.0%, +1,000 bps YoY (vs 35% prior year) attributed to higher revenue, improved manufacturing capacity utilization, and favorable product mix
  • Non-GAAP net income Q4 $3.6M or $0.11/diluted share, above Street consensus (vs non-GAAP net loss of $0.2M or -$0.01/diluted share in Q4 FY25)
  • Q4 bookings $60.7M, +500%+ YoY from $11.1M; backlog record $80.6M (+ from $15.2M FY25). Additional ~$20M bookings in transition period into FY27 increased effective backlog to ~$100.6M
  • FY26 revenue $50M (-15% YoY); FY26 non-GAAP gross margin 38.5% (down from 44%); FY26 non-GAAP net income $0.9M ($0.03/diluted) vs $4.6M ($0.15/diluted) in FY25
  • FY27 guidance: revenue $130M-$150M (+160% to +200% YoY) with non-GAAP pretax profitability at 18%-22% of revenue (no memory revenue assumed in the $150M top-line scenario)
  • Tax/tariff impacts: not explicitly quantified in the transcript provided

AI IconCapital Funding

  • Cash: $116.5M cash/cash equivalents/restricted cash at Q4 end vs $26.5M at FY25 end
  • Funding: raised ~$100M during FY26 primarily via ATM program
  • Capital expenditures: $2.1M in FY26 (capital-light profile emphasized)

AI IconStrategy & Ops

  • Manufacturing capacity expansion: shipping Sonoma systems from an existing Southeast Asia contract manufacturer; adds capacity for >20 Sonoma systems/month
  • Fremont expansion plus contract manufacturer scaling to avoid fixed-cost buildout; emphasis on meeting potentially large single-customer orders without multi-year build times
  • New customer-support footprint: signed a new lease to expand office in Hsinchu, Taiwan to increase local sales/support and strengthen ecosystem engagement
  • Automation/throughput: WaferPak FOX approach and Wafer-level throughput claims (process up to 1/4 wafer at a time; up to 9 wafers parallel) and Sonoma high-power configuration designed for continuous flow with higher per-device power (2,000W+), optional integrated auto-aligner, and hands-free loader/unloader

AI IconMarket Outlook

  • FY27 revenue guidance: $130M-$150M (2.6x to 3.0x FY26 revenue); backed by record backlog and customer forecasts
  • FY27 non-GAAP pretax profitability: 18%-22% (as stated as pretax % of revenue)
  • No memory revenue assumed within FY27 $130M-$150M range; memory upside framed as potential beyond current year assumptions

AI IconRisks & Headwinds

  • Silicon carbide recovery described as still subject to order confirmation (management referenced a 'wait and see' posture historically; current year shows more specific forecasts but remains order-driven)
  • Memory development execution risk: management said a committed customer (PO/sponsorship) and alignment on price/testability remains unresolved; expects not to build models with meaningful memory revenue for the next year
  • Capacity/throughput remains operationally constrained to one shift at Aehr facility even after capacity growth; reliance on contract manufacturing is needed to scale output without excessive fixed infrastructure
  • Patent litigation: ongoing legal expenses in China tied to SemiNexus Test; case still ongoing despite Beijing district upholding 2 Chinese patents (ongoing uncertainty and cost exposure)

Q&A: Analyst Interest

  • Topic: FY27 product mix assumptions and whether memory revenue is included: Management stated mix is approximately AI ~70%, silicon photonics ~15%-20%, with power/misc as the remainder. They also explicitly do not anticipate any memory revenue within the $130M-$150M guidance range; any memory-related upside would be incremental to the current plan.
  • Topic: Memory roadmap timing, confidence level, and how HBM/HBF flash shifts testability: Management said confidence is only moderately improved versus last quarter because they have started resourcing (hired people, architecture schematics, software/board-layout work), but still need a committed customer and aligned buy economics. They highlighted high-bandwidth memory standards embedding BIST, which may help their test approach; still not modeling revenue next year.
  • Topic: Top-line revenue capacity and practical ability to scale beyond Fremont without fixed-cost risk: Management explained that while system/chamber/blade/subsystem supply comes from contract manufacturers and only ~1 shift runs internally, they have outsourced/expanded capacity to ship quickly. They cited >20 Sonoma systems/month capacity from a Southeast Asia contract manufacturer without impacting Fremont capacity, and emphasized discipline to avoid permanent fixed infrastructure buildup for cyclical demand.

Sentiment: POSITIVE

Note: This summary was synthesized by AI from the AEHR Q4 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

📋 Official Regulatory 10-K / 10-Q SEC Filings

Direct authenticated documentation links to audited SEC database reports for AEHR.

SEC EDGAR Live Feed
Loading financial data and tables...
📁

SEC Filings (AEHR)

© 2026 Stock Market Info — Aehr Test Systems (AEHR) Financial Profile